Cinguloparietal Atrophy Distinguishes Alzheimer Disease From Semantic Dementia
Open Access
- 1 July 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 60 (7) , 949-956
- https://doi.org/10.1001/archneur.60.7.949
Abstract
NEW TREATMENTS for Alzheimer disease (AD) have been designed to target specific components of the AD neurodegenerative mechanism and are thus unlikely to be useful in other forms of dementia. For this reason, it will be important to distinguish other common causes of dementia, including vascular disease, Lewy body disease, and Pick complex disorders, from AD at early stages of the disease, when strategies to decrease brain β-amyloid levels will have the largest potential benefit. Neuroimaging is a useful tool in the diagnosis of dementia.118Fluorodeoxyglucose positron emission tomography of AD shows early parietal and cingulate hypometabolism, which is predictive of progression to dementia2 and is specific to AD.3Keywords
This publication has 16 references indexed in Scilit:
- Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from ADNeurology, 2002
- Patterns of brain atrophy in frontotemporal dementia and semantic dementiaNeurology, 2002
- Beyond the hippocampusNeurology, 2001
- Calculation difficulties in children of very low birthweight: A neural correlateBrain, 2001
- Practice parameter: Diagnosis of dementia (an evidence-based review)Neurology, 2001
- Voxel-Based Morphometry of Herpes Simplex EncephalitisNeuroImage, 2001
- Memory and MRI-based hippocampal volumes in aging and ADNeurology, 2000
- Prediction of AD with MRI-based hippocampal volume in mild cognitive impairmentNeurology, 1999
- Frontotemporal lobar degenerationNeurology, 1998
- A Voxel-Based Method for the Statistical Analysis of Gray and White Matter Density Applied to SchizophreniaNeuroImage, 1995